FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
-
最新报道：The U.S. FDA plans to factor in drug affordability when accelerating approvals for new medications, according to Commissioner Dr. Scott Gottlieb. This shift aims to balance faster access to treatments with concerns over rising healthcare costs. The agency will weigh pricing data alongside safety and efficacy in its accelerated approval process, particularly for breakthrough therapies targeting serious conditions. Critics argue this approach could delay life-saving drugs, while supporters say it addresses systemic affordability issues. The policy change follows growing scrutiny of pharmaceutical pricing practices and their impact on patients.
下一篇
CoinWorld Evening Analysis: Ethereum ETH Price Forecast
- 最近4小时K线显示价格相比2025-07-11 00:00:00大幅下跌，比2025-07-10 12:00:00有所回升，比2025-07-10 20:00:00有所下降，小阳柱...
24小时热点
热点专题
418154